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Highlights 
 Purkinje Cell specific genes highlight pathways converging onto calcium signaling  
 Calcium signaling contributes to Purkinje cell vulnerability for SCA mutations  
 Unique Purkinje Cell genes might be candidate - or modifier genes of SCA disease 
Abstract 
The genetically heterozygous spinocerebellar ataxias are all characterized by cerebellar 
atrophy and pervasive Purkinje Cell degeneration. Up to date, more than 35 functionally 
diverse spinocerebellar ataxia genes have been identified. The main question that remains 
yet unsolved is why do some many genetic insults lead to Purkinje Cell degeneration and 
spinocerebellar ataxia? To address this question it is important to identify intrinsic pathways 
important for Purkinje Cell function and survival. In this review, we discuss the current 
consensus on shared mechanisms underlying the pervasive Purkinje Cell loss in 
spinocerebellar ataxia. Additionally, using recently published cell type specific expression 











pathways might underlie the vulnerability of Purkinje Cells in response to the diverse genetic 
insults causing spinocerebellar ataxia.  
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Autosomal dominant cerebellar ataxias (ADCAs) are a group of hereditary 
neurodegenerative disorders caused by pervasive Purkinje Cell (PC) loss in the 
cerebellum. These disorders are also referred to as spinocerebellar ataxias (SCA) by 
genetic nomenclature [1]. For now, 49 subtypes of SCA for which 37 causative genes 
are identified (Table 1). The genetically diverse SCA type are relatively homogeneous 
in their clinical presentation as they are all characterized by cerebellar ataxia, but can 
also be accompanied by additional signs and symptoms [1,2]. In general, patients 
experience problems with their coordination and balance, poor hand-eye coordination, 
dysarthria, and involuntary eye movements.  
 Genetically, SCA can be classified into the following two categories: 1) non-
conventional SCA types and 2) conventional SCA types. The first group of SCAs is 
caused by expansions of coding CAG repeats encoding long stretches of 
polyglutamine (polyQ) and include SCA1-3, 6, 7, and 17, or by non-coding repeat 
expansions in either untranslated regions  (UTRs) or intronic regions including SCA8 
(CTG or CAG repeats depending on the direction of transcription), SCA10 (ATTCT 
repeats), SCA12 (CAG repeats), SCA31 (TGGAA repeats), and SCA36 (GGCCTG 
repeats), and SCA37 (ATTTC repeat) [1,3,4]. In recent years the second group of 
SCAs is growing as more SCAs due by conventional mutation are found by next 
generation sequencing. This group includes missense mutations, as for in example 
SCA5, 13, 14, 19/22, and 23, and large duplications or deletions of single genes or 
gene regions that cause SCA15/16, SCA20, and SCA39 [1,5-8]. These different 
mutations in functionally diverse SCA genes all lead to pervasive PC loss, however 











Recent scientific advances have begun to shed light on the shared pathogenesis of 
the genetically heterogeneous SCAs. To elucidate the shared route to pervasive PC 
degeneration, researchers often used the reported SCA genes as staring point [9-12]. This 
has led to the identification of several potential mechanisms underlying SCA. These 
mechanisms include, but are not limited to, protein misfolding and aggregation, toxic RNA 
gain-of-function, transcriptional dysregulation, and alterations in glutamate and calcium 
signaling affecting synaptic transmission. The misfolding and accumulation of proteins is the 
hallmark of polyQ-SCA types (see Table 1), however, also repeat-containing RNA may 
aggregate as for example is seen in SCA8, 31, and 36 [13-15]. These so-called RNA-foci 
accumulate in PCs and sequester RNA binding proteins that in the long run will affect RNA 
splicing, translational regulation, and other effects leading to neurotoxicity. Additionally, 
transcriptional dysregulation contributed to PC loss and cerebellar dysfunction due to loss of 
ataxin-1 function (SCA1) [16], and polyQ-expanded ataxin-3 (SCA3) [17]. The C-terminal part 
of the Cav2.1 subunit (1ACT; SCA6) containing a normal poly-Q tract length is a 
transcription factor mediating transcription of several PC genes and rescued the pathology 
of SCA6 mouse [18]. Similarly to 1ACT, ataxin-7 (SCA7) as an integral subunit of the TATA-
box binding protein (TBP)- free TBP associated factors (TAF) complex [19] and TBP (SCA17) 
also directly regulate transcription (reviewed in 20). Dysregulation of calcium signaling in PCs 
is one of the major disease mechanisms unerlying conventional SCA types caused by 1) 
mutations in voltage-gated calcium channels including CACNA1A (SCA6) and CACNA1G 
(SCA42) [21,22]) and voltage-gated potassium channels KCNC3 (SCA13) and KCND3 
(SCA19/22) [5,6,23], 2) by mediating calcium release from intracellular stores as seen in 
SCA15/16/29 due to mutations in ITPR1 encoding the InsP3 receptor type 1 or 3) regulation 
of mitochondrial calcium influx controlled by AFG3 Like Matrix AAA Peptidase Subunit 2 
encoded by AFG3L2 (SCA28) [24-27]. In the end, all these underlying mechanisms are 











cerebellar dysfunction that are ultimately the causes of the pervasive loss of PCs resulting in 
SCA. Given that many reviews were published on these consensus disease mechanisms they 
will not be the focus of this work. 
 Some of the reported SCA genes do not fit into the consensus disease mechanisms 
listed above, demonstrating that other disease mechanisms may play a role in the SCA 
pathogenesis. To better understand how and why so many genetic insults can lead to 
pervasive PC degeneration and SCA, we need to understand what makes PCs so vulnerable 
for particular genetic insults compared to other neurons in the cerebellum such as granule 
cells, stellate and basket cells, or Bergman glia cells, and astrocytes.  
Purkinje cells and SCA  
PCs are large pear-shaped neuronal cells characterized by a large dendritic arbor decorated 
with thousands of little spines and a single axon originating from the other end. PC somas 
align in the cerebellar cortex to form the PC layer that lies in between the outer molecular 
layer, and inner granular cell layer. PCs integrate the large number of input signals from the 
parallel fibers (PF) of granule cells and climbing fibers (CF) coming out of the inferior olivary 
nucleus, and conveys the sole output signal from the cerebellar cortex to the deep cerebellar 
nuclei (DCN), which sends projections back to the brainstem and the cerebral cortex via the 
thalamus. This loop is called the cerebellar cortex–DCN–thalamus–cerebral cortex feedback 
loop (for recent reviews of cerebellar architecture and function see 28,29). The interaction 
of PC-CF and PC-PF inputs generates a unique form of heterosynaptic plasticity in PCs that 
has been shown to underlie motor learning (reviewed in 30). PCs provide the signals that are 
required for planning, performing and fine-tuning of movement and coordination, and 
consequently dysfunction and/or loss of PCs leads to cerebellar ataxia.  
The question remains why PCs are vulnerable for the many genetic insults leading to 











noticeable dendritic three with many branching extensions. Dendritic arborization is 
amongst others regulated by mitochondrial fission and mitochondrial transport [31], 
implying that proper regulation of energy supply is important for the developing dendritic 
tree of PCs. Vise versa, maintaining proper energy supply is important for PC survival as 
altered mitochondrial dynamics led to PC degeneration in SCA3 mouse [32] and alterations 
in the bioenergetic machinery was observed in SCA1 mouse cerebella [33]. Additionally, 
mutations in AFG3L2 encoding AFG3-like AAA ATPase 2 cause SCA28 and loss of the m-AAA 
protease resulted in the accumulation of the mitochondrial Ca2+ uniporter MCU leading to 
mitochondrial calcium overload and subsequently neurodegeneration [27,34]. Another 
hallmark of PCs is their highly intrinsic activity and spontaneous action potential firing in the 
absence of synaptic input. Alterations in spontaneous PC firing has been seen in several SCA 
mouse models and other mouse models exhibiting ataxia due to mutations in genes 
important for PC and cerebellar functioning (reviewed in 35). Nevertheless, the exact 
molecular mechanisms underlying the pervasive PC vulnerability in SCA remains yet 
unknown. 
Purkinje cell-enriched pathways 
Comparative analysis can provide insights into cell-type specific and enriched transcripts for 
each cell population and at such can be used to identify intrinsic molecular components and 
corresponding pathways that could play a role in the specific neuronal degeneration. We 
hypothesized that by identifying PC specific genes we are able to highlight pathways that 
may give clues into the molecular mechanisms what makes PCs different from other neurons 
and glia in the cerebellum and why so many genetic insults can lead to PC degeneration in 
SCA. We made use of a publically available data set generated by Doyle et al [36]. In this 
study, transcription profiles of 24 CNS cell populations were generated using a Translating 
Ribosome Affinity Purification (TRAP) approach and were used in a complex comparative 











did not cluster strongly with other cell types. By a comparative analysis using data presented 
in Table S5 from Doyle et al., we identified 1029 PC-specific genes as they were not detected 
in cerebellar granule cells, cerebellar golgi cells, mature cerebellar oligodendrocytes 
(Cmtm5), a mixed mature and progenitor cerebellar oligodendrocyte population (Olig2), and 
cerebellar astrocytes (Figure 1 and Supplementary Tables 1). Using the DAVID gene 
accession conversion tool, we were able to convert these 1029 mouse transcripts to 491 
human genes  (Supplementary Table 2). This list of unique PC genes contained the known 
SCA genes ITPR1, AFG3L2, TRPC3, and CACNA1G, suggesting that these genes are 
functionally very important for PCs and further validates their role in the pathogenesis of 
SCA. Notably, all four genes are regulators of intracellular neuronal calcium homeostasis by 
either controlling mitochondrial calcium uptake (AFG3L2)[37,38], release of calcium from 
post-synaptic endoplasmatic reticulum stores (ITPR1) [39], regulating mGluR1-mediated 
calcium signaling (TRPC3) [40], and contribute to fast calcium signaling within PC dendritic 
spines (CACNA1G) [41]. Balanced calcium signaling is evidently crucial for neuronal 
functioning but also for neuronal survival as is shown by the increasing number of genetic 
mutations in calcium-mediating proteins causing neurodegenerative disorders including SCA 
and episodic ataxias (reviewed in 42). This observation further substantiates altered calcium 
homeostasis as an emerging shared pathway in the pathogenesis of SCA. Additionally, we 
performed a pathway analysis using the web-tool ConsensusPathDB [43] and this program 
predicted 4 pathways to be enriched in PCs using the unique PC transcripts as seeds (p-value 
< 0.0005)(Table 2) including 1) phosphatidylinosytol signaling system and inositol phosphate 
metabolism, 2) Huntington’s disease, 3) (p38) MAPK signaling, and 4) nuclear receptor 
signaling. In the next section, we will discuss these biological pathways and their potential 
role in PC function and viability, and SCA pathogenesis. 











PC activity is dependent of phosphatidylinositol signaling, as the inositol 
trisphosphate receptor type 1 (InsP3R1/ITPR1)(Table 2) is the key receptor in PCs 
that regulates the interaction between CF and PF inputs on PC dendrites and thus links 
the different levels of synaptic activity of long term potentiation to long term 
depression (LTD). In contrast to other neurons that use ryanodine receptors to release 
calcium from intracellular stores, PCs exhibit dense concentrations of InsP3R1 on 
their post-synaptic ER stores [39]. InsP3R1 mediates local calcium release via binding 
to the second messenger inositol 1,4,5-trisphosphate (IP3) that induces complex 
spatiotemporal patterns of calcium waves and oscillations required for the induction 
of LTD [44]. The crucial role of InsP3R1-mediated calcium signaling in PCs is 
underscored by the fact that deletions in ITPR1 induce ataxia in mice and 
SCA15/SCA16 in humans [24]. The complexity of InsP3R1-mediated calcium 
signaling is further illustrated by the identification of recessive truncating mutations 
and/or de novo mutations in ITPR1 underlying Gilespie syndrome characterized by 
congenital ataxia, intellectual disability and iris hypoplasia [45]. Recently, mutations 
were identified in GRM1 encoding the metabotrophic glutamate receptor mGluR1 that 
triggers IP3 production upon PF stimulation to cause SCA44 [46]. Functional 
impairment of mGluR1 signaling was also observed in mouse SCA3 PCs [47], and 
mGluR1 mutant mice showed pronounced motor deficits, ataxic features and were 
deficient in cerebellar LTD affecting motor learning [48]. Mouse exhibiting mutant 
Inpp4a and Inpp5a (Table 2), encoding inositol 4/5-phosphatases catalyzing the 
removal of the 4/5-position phosphate from IP3 facilitating IP3 inactivity, exhibit 
severe ataxia, lethality (only the Inpp4awbl mice), and PC degeneration [49,50]. In 
addition, a mutation in ring finger protein 170 (RNF170) causes a dominant inherited 











cells expressing mutant RNF170 showed reduced Ca2+ mobilization that was not due 
to altered IP3 production or InsP3R1 ubiquitination [52]. How mutant RNF170 alters 
InsP3R1-mediated calcium signaling and if this is the cause of the PC degeneration 
seen in patient s remains to be investigated.  
Despite its clearly crucial role in PCs, InsP3R1-mediated calcium signaling also has 
been reported to play a role in pathogenesis of the neurodegenerative disorders presenilin-
linked familial Alzheimer’s disease (AD), sporadic amyotrophic lateral sclerosis (ALS), and 
Huntington’s disease (HD) [53-55]. This finding shows that InsP3R1-mediated calcium 
signaling is also important in regulating the survival of other neuronal cell types and 
therefore, cannot by itself explain why so many genetic insults lead to pervasive PC 
degeneration seen in SCA. 
Huntington’s disease 
Huntington Disease (HD) is like SCA an autosomal dominant neurodegenerative disorder 
caused by a coding polyQ-repeat expansion in the Huntingtin (HTT) gene. The disease affects 
mainly neurons in the striatum, basal ganglia and the cortex. However, evidence is 
accumulating for a role of the cerebellum and PCs in early HD pathology. Cerebellar atrophy 
as well as PC loss was observed in HD postmortem tissue that did not correlate with the level 
of striatal atrophy [56], suggesting that the cerebellar atrophy is an independent event in HD 
pathogenesis. Marked PCs loss was detected in a juvenile HD mouse model (R6/2) at 12 
weeks of age as well in a knock-in mouse model of HD (HdhQ200) that coincided with PC 
dysfunction [57]. In the end, the loss of PCs in the cerebellum might explain the ataxia, 
dysarthria, gait abnormalities and imbalance of the stature seen in many HD patients. 
The HTT protein is involved in several important processes in neurons, amongst 
other in regulation of endocytosis, neuronal secretion and intracellular transport of Brain-











that very much resembled the pathology seen in stargazer (stg) mouse exhibiting a severe 
ataxia [59]. Remarkably, a selective defect in BDNF expression was observed in the cerebella 
of stg mouse and overexpression of BDNF was able to alleviate the ataxic symptoms and 
restored cerebellar architecture of stg mouse [60]. In SCA6 human cerebellum decreased 
levels of BDNF mRNA were observed that coincided with BDNF-immunoreactive granules in 
the dendrites of SCA6 PCs [61]. Mutant HTT was also reported to activate N-methyl-
aspartate (NDMA) receptors via sensitizing InsP3R1 (Table 2) to IP3 via its interaction with 
the C-terminus of InsP3R1 [55,62]. Both mutant ataxin-2 and ataxin-3 proteins containing 
polyQ-repeat expansions were also found to bind to the C-terminus of InsP3R1 leading to its 
sensitization to activation by IP3 [63,64]. These findings highlight deranged InsP3R1-
mediated Ca2+ signaling as an important pathway underlying the pervasive PC degeneration 
in SCA.  
Additionally, many studies reported dysfunctional handling of Ca2+ load in 
mitochondria isolated from HD patients and from different HD mouse (reviewed in 65,66). 
Defects in the mitochondrial respiratory chain affecting the complexes II and IV of R6/2 mice 
in vitro, whereas defects in complex 1 have also been described in the muscles of HD 
patients [67,68]. Several of these complex I protein members including NDUFA6, NDUFC1, 
NDUFA4, NDUFA2 showed relatively restricted expression to PCs (Table 2). Not surprisingly, 
it has become quite evident that mitochondrial dysfunction and bioenergetic perturbation 
leads to dysfunction of the spinocerebellar system and have been reported as a frequent 
cause underlying the pervasive PC degeneration in SCA. Mitochondrial dysfunction in 
relation to SCA will not be further discussed in this work.  
Mutant HTT interacts and/or sequesters and thereby reduces the normal function of 
several transcription factors including TBP (SCA17) (Table 2) [69]. Moreover, HTT may act by 











leading to transcriptional changes [70,71], and subsequently mutant HTT leads to 
transcriptional abnormalities. Interestingly, several Huntington-like cases indistinguishable 
from “real” HD but with cerebellar ataxia carried an expanded polyQ-repeat in the TPB gene 
[72]. Whether HD and SCA17 exhibit similar transcriptional changes need to be investigated 
but these studies may suggest an overlap in pathogenesis between HD and SCA. 
(p38) MAPK signaling  
Mitogen-activated protein kinases (MAPKs) signaling is a key process that regulates 
numerous cellular processes including proliferation, differentiation, apoptosis, and survival 
(reviewed in 73), and its activation is highly dependent on intracellular calcium levels. Many 
genes directly or indirectly involved in calcium signaling seem to have a restricted expression 
in PCs including CACNB2, PRKCA, CACNG2, CACNA1G, MKNK1, MAPKAPK2, PTPRR and others 
(Table 2). Several MAPK cascades have been identified of which extracellular signal-
regulated kinseses-1 and -2 (ERK1 and ERK2) are the most studied but also include c-Jun N-
terminal kinases (JNKs), and p38 MAPK. Interestingly, upstream regulators such as Ras, 
protein kinase C gamma (PKC), protein tyrosine phosphatases (PTPRR) and several 
downstream targets of ERKs are highly expressed in mature postmitotic neurons and/or in 
PCs. ERK activation is amongst other regulated by excitatory glutamatergic signaling [74,75], 
a pathway recognized to play a crucial role in the pathogenesis of SCA [11]. Recently, it was 
shown that MAPK/ERK regulates Group 1 metabotrophic glutamate receptors (mGluR1 and 
mGluR5) and modifies the cell surface expression of these receptors via site-specific 
phosphorylation [76]. This interaction between ERK and mGluR1 occurs at synaptic sites and 
apparently plays an essential role in synaptic plasticity by controlling LTP and spatial 
memory. The role of the MAPK signaling and synaptic plasticity is reviewed in [77].  
Several components of the Ras–MAPK–MSK1 pathway including ERKs were reported 











neurodegeneration was suppressed upon silencing of these components in both Drosophila 
and mice [78]. Additionally, aberrant MAPK signaling via reduced ERK phosphorylation and 
compromised nuclear translocation of ERK was shown to underlie SCA14 [79]. Given the 
essential role of PKC in cerebellar LTD [80,81], SCA14 PCs showed impaired pruning of CF 
synapses and failure of LTD expression affecting synaptic plasticity [82]. Increased 
phosphorylation levels of ERKs were detected brain tissue of mouse lacking all four PTPRR 
isoforms which are predominantly expressed in the PCs [83]. These Ptprr knockout mice 
developed problems with fine motor coordination, grip, and balance without obvious 
morphological changes in brain and PC morphology up to 20 months of age. Additionally, 
these mice exhibit impaired cerebellar LTD that was correlated to deficient a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) phosphorylation and 
internalization [84]. These datasets further underscore a role for MAPK signaling in 
regulating cerebellar motor function and suggest that MAPK/ERK signaling is required for PC 
function in cerebellar LTD and that abnormal MAPK/ERK signaling may lead to PC 
dysfunction rather than PC degeneration. 
The p38 MAPK cascade might regulate a distinct form of synaptic plasticity 
contributing to LTD compared to MAPK/ERK signaling and involves the activation of NMDA-
Rs and mGluRs [85,86]. p38 MAPK was shown to control associative learning, as a specific 
inhibitor of p38 infused in the cerebellar vermis prevented classical eye-blink conditioning 
[87]. Both paired and unpaired eye-blink conditioning affected PC morphology causing 
reduced dendritic tree length and size, and reduced number of spiny branch arbors [88]. 
Notably, defects in the acquisition of classical eye-blink conditioning were also reported in 
the severely ataxic stg mouse [89], linking the p38 MAPK cascade to cerebellar motor 
function and ataxia. 











Nuclear receptors are ligand-activated transcription factors that play a key role in metabolic 
and developmental pathways regulate cellular processes including lipid and glucose 
homeostasis, detoxification, and differentiation [90]. Nuclear receptors also play key roles in 
the central nervous system since the brain has a very high lipid content and is metabolically 
very active (reviewed in 91). The most abundant nuclear receptors in the brain are 
peroxisome proliferation-activated receptors (PPARs) and liver X receptors (LXRs) that 
function as lipid and cholesterol sensors, respectively, and couple the size of the metabolic 
machinery to metabolic demand. However, other (inter-) nuclear receptors are also 
expressed in brain and PCs and include retinoid-related orphan receptor  (ROR), 
progesterone receptors (PGR) also called nuclear receptor subfamily 3 group C, member 3 
(NR3C3), orphan nuclear receptor (NR3B2/ESRRB) and TR4 orphan receptor (NR2C2), nuclear 
receptor subfamily 2 group F, member 6 and 2 (NR2F6 and NR2F2)(Table 2).  
The importance of lipid homeostasis in PC functioning and survival is underscored by 
the fact that mutations in ELOVL5, and ELOVL4 encoding elongases 4 and 5, involved in the 
synthesis of very-long-chain fatty acids with more than 16 carbons cause SCA34 and SCA38 
[92,93]. Additionally, SCA genes FAT1 and FAT2 [94] were shown to promote omega-3 long-
chain polyunsaturated fatty acids synthesis in transgenic fish expressing humanized fat1 and 
fat2 genes [95]. Furthermore, alkanine ceremidase 3 (Acer3) a precursor of the bioactive 
lipid sphingosine-1-phosphate (S1P) plays a crucial role in PC development as Acer3 
knockout mouse suffered from premature PC degeneration and cerebellar ataxia. Acer3 
deficiency led to accumulation of total levels of ceremides and dyshomeostasis of their 
sphingolipid derivatives including S1P in the cerebellum [96]. Supporting evidence that 
proper control of ceremide biosynthesis is necessary to control PC viability is given by the 
fact that spontaneous mutations in Lass1 encoding (dihydroc)ceramide synthase 1 caused 











Upon administration of a LXR receptor agonist, increased dendritic tree growth of 
PCs and migration of granule cell neurons was observed during cerebellum development 
[98]. In contrast, genetic ablation of LXRs caused deficits in motor coordination, spatial 
learning and myelination in the cerebellum that was not caused by large morphological 
structural changes or degeneration of cerebellum of LXR knockout mice but rather was due 
to loss of motor neurons in the spinal cord mimicking features seen in amyotrophic lateral 
sclerosis (ALS) [99,100].  
Staggerer mice with severe ataxia and not well-developed PCs were shown to carry 
a spontaneous deletion in Roraencoding RORTable 2)[101].  Ror deficient mice 
validated Ror’s role in the development of the cerebellum and PCs as these mice displayed 
motor deficits that were almost identical to staggerer mouse [102]. Anatomically both mice 
models revealed identical abnormalities that included a small cerebellum with a thin 
molecular layer and an almost absent granule cell layer. Furthermore, PCs were not aligned 
in a monolayer and exhibited small undifferentiated dendrites without small spine branches 
and were still innervated by multiple CFs [102,103]. Altered expression of Ror target genes 
and reduced Ror protein levels were observed in presymptomatic SCA1 mouse [104]. 
Additionally, partial loss of Ror led to a more severe SCA1 disease phenotype and 
pathology. Reduced Ror protein levels and reduced Rora mRNA levels were also seen in 
mouse SCA3 PCs and mouse ataxin2 knockout and ataxin2-CAG43 knockin cerebella, 
respectively [47,105]. Therefore, the abnormal phenotypes in the cerebella of the SCA2 and 
SCA3 mice may very likely be the result of aberrant Rorα-mediated transcription. 
Interestingly, Ror regulates the expression of numerous key genes in the developing 
cerebellum involved in calcium signaling including Pcp4, Itpr1, Cals1, and Calb1 [106] and 
reduced levels of these targets were found before the onset of PC loss in staggerer mouse. 
This suggests that these gene expression changes are not a secondary effect of the 











This latter data implies that key events such as proper ROR expression during PC 
development plays a crucial role in the susceptibility of PCs and again highlights calcium-
dependent pathways as proposed molecular mechanisms in SCA. 
General conclusions and perspectives 
Only two decades after the discovery of the first genetic cause of SCA, technological 
advances in genetics has led to the rapid identification of over 35 functionally diverse SCA 
genes. The question why do so many genetic insults lead to pervasive PC degeneration and 
SCA remains yet partly unanswered. However, others and we suggest that the answer to this 
question lies within the unique characteristics of PCs compared to other neurons in the 
cerebellum. Therefore, it is crucial to increase our understanding of these underlying 
molecular mechanisms and corresponding pathways that are fundamental for dysfunction 
and degeneration of PCs in SCA.  
In this review, we discussed the current knowledge on the consensus mechanisms 
underlying SCA and highlighted specific pathways that are very likely crucial for PC function 
using publically available cell type specific expression data. The pathways that were 
identified during our analysis included phosphatidylinositol signaling system and inositol 
phosphate metabolism, Huntington’s disease, (p38) MAPK signaling, and nuclear receptor 
signaling and seemingly all converge onto intracellular calcium homeostasis. Another study 
identified 2 SCA transcript-enriched modules in control (non-SCA) postmortem cerebellar 
tissue by investigating regional differences in gene expression [108]. One of these modules 
contained several transcripts involved in calcium signaling also pointing towards an 
important role of calcium-mediated signaling in the pathogenesis of SCA. Generally, we 
hypothesize that any genetic insult that may alter directly or indirectly intracellular calcium 











The list of unique PC genes may very likely contain candidate disease genes for 
genetically undiagnosed SCA cases or may contain disease modifiers. This is nicely illustrated 
by the observation that elevated levels of PC-specific gene Cck  Supplementary Table 2) 
encoding cholecystokinin was shown to activate a neuroprotective pathway via binding to 
Cck1R in the cerebella of Atxn1-[30Q]-D776 transgenic mice preventing progressive PC 
degeneration [109]. The identification of key pathways specific for PC function and survival 
using unbiased approaches will help to direct future studies on interfering with the 
molecular mechanisms of neurotoxicity in different stages of the disease. 
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Figure 1: Gene sharing within cerebellar cell types. Venn diagram of gene sharing between 
six cerebellar cell types including Purkinje Cells, cerebellar granule cells, cerebellar golgi 
cells, cerebellar oligos (mature oligodendrocytes; Cmtm5), cerebellar oligos (mixed 
population of mature and progenitor oligodendrocytes;Olig2), and cerebellar astrocytes. 
Numbers in parentheses are the total number of genes found for that cell type; numbers in 
intersections show the total number of genes shared between given combinations of 
























Protein name  
Reference 
SCA1 ATXN1 164400 6p22.3 (polyQ)n Ataxin-1 [110] 
SCA2 ATXN2 183090 
12q24.
12 
(polyQ)n Ataxin-2 [111,112] 
SCA3 ATXN3 607047 
14q32.
12 
(polyQ)n Ataxin-3 [113] 
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Table 2: List of Purkinje cell pathways  
Pathway Source Gene symbols p-value 
Phosphatidylino
sitol signaling  
 
KEGG DGKZ; INPP5A; PLCB3; INPP5D; INPP5E; PRKCA; 
CDS1; PIP5K1A; INPP4A; ITPKA; IMPA1; DGKH; 




KEGG NDUFA6; NDUFC1; NDUFA4; PLCB3; NDUFA2; 
GNAQ; SOD1; TGM2; CYCS; CASP9; GPX1; COX6C; 
PPIF; POLR2L; ITPR1; ATP5G1; AP2B1; POLR2K 
1.79 x 10-5 
MAPK signaling  KEGG RELA; TGFB1; TGFB2; RPS6KA3; PTPRR; PPM1A; 
NLK; MKNK1; CACNB2; FGF11; RAP1B; DUSP10; 
MEF2C; PRKCA; MAP4K2; FGF7; CACNG2; 





KEGG INPP5A; PLCB3; INPP5D; INPP5E; PIP5K1A; 
INPP4A; ITPKA; IMPA1; PI4K2A; MTMR7 





ESRRA; ESRRB; NR2F6; RORA; NR2F2; NR2C2; 
PGR 




BioCarta NR2C2; MAP3K9; MKNK1; MEF2C; MEF2D; 
MAPKAPK2 
3.11 X 10-3 
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